Your browser doesn't support javascript.
loading
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
Sacco, Assuntina G; Chen, Ruifeng; Worden, Francis P; Wong, Deborah J L; Adkins, Douglas; Swiecicki, Paul; Chai-Ho, Wanxing; Oppelt, Peter; Ghosh, Debanjali; Bykowski, Julie; Molinolo, Alfredo; Pittman, Emily; Estrada, M Valeria; Gold, Kathryn; Daniels, Gregory; Lippman, Scott M; Natsuhara, Amanda; Messer, Karen; Cohen, Ezra E W.
Afiliação
  • Sacco AG; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA. Electronic address: agsacco@health.ucsd.edu.
  • Chen R; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA; Division of Biostatistics, Herbert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA.
  • Worden FP; Rogel Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Wong DJL; Los Angeles Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Adkins D; Siteman Comprehensive Cancer Center, Washington University, St Louis, MO, USA.
  • Swiecicki P; Rogel Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Chai-Ho W; Los Angeles Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Oppelt P; Siteman Comprehensive Cancer Center, Washington University, St Louis, MO, USA.
  • Ghosh D; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Bykowski J; Department of Radiology, University of California, San Diego, La Jolla, CA, USA.
  • Molinolo A; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Pittman E; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Estrada MV; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Gold K; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Daniels G; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Lippman SM; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Natsuhara A; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  • Messer K; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA; Division of Biostatistics, Herbert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA.
  • Cohen EEW; Moores Comprehensive Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Lancet Oncol ; 22(6): 883-892, 2021 06.
Article em En | MEDLINE | ID: mdl-33989559
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Cetuximab / Carcinoma de Células Escamosas de Cabeça e Pescoço Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Cetuximab / Carcinoma de Células Escamosas de Cabeça e Pescoço Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido